Insulet (PODD) Return on Capital Employed (2011 - 2026)
Insulet's (PODD) quarterly Return on Capital Employed came in at 21.12% in Q1 2026, up 888.0% YoY from 2.14% in Q1 2025, and up 8.29% on a QoQ basis from 19.5% in Q4 2025.
Insulet (PODD) Return on Capital Employed (2011 - 2026) Analysis & Trends
Insulet (PODD) has 16 years of Return on Capital Employed data on file, last reported at 21.12% in Q1 2026.
- Quarterly Return on Capital Employed rose 888.0% year-over-year to 21.12% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 21.12% (up 888.0% YoY) and the FY2025 annual result came in at 19.27%, up 589.0% from the prior year.
- Return on Capital Employed rose to 21.12% in Q1 2026, from 19.5% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 21.12% in Q1 2026 to a low of 1.45% in Q1 2023.
- A 5-year average of 10.38% and a median of 11.47% in 2024 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed tumbled 655 bps — and 2024, when it soared 1002 bps.
- Tracing PODD's Return on Capital Employed over 5 years: stood at 2.04% in 2022, then soared by 420 bps to 10.6% in 2023, then increased by 15 bps to 12.21% in 2024, then surged by 60 bps to 19.5% in 2025, then grew by 8 bps to 21.12% in 2026.
- The last three Return on Capital Employed figures came in at 21.12% (Q1 2026), 19.5% (Q4 2025), and 16.79% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.25 Bn | 196.65 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 127.36 Bn | 123.89 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.03 Bn | 109.81 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 74.45 Bn | 73.91 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.81 Bn | 47.55 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 35.04 Bn | 33.10 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.84 Bn | 31.73 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.25 Bn | 22.93 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.18 Bn | 22.70 Bn | 684.20 Mn | 12.08% |
| 10 | Insulet | 10.35 Bn | 9.82 Bn | 562.60 Mn | 22.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.12% |
| Mar 31, 2026 | 21.12% |
| Dec 31, 2025 | 19.50% |
| Sep 30, 2025 | 16.79% |
| Jun 30, 2025 | 16.40% |
| Mar 31, 2025 | 12.25% |
| Dec 31, 2024 | 12.21% |
| Sep 30, 2024 | 12.50% |
| Jun 30, 2024 | 12.03% |
| Mar 31, 2024 | 11.47% |
| Dec 31, 2023 | 10.60% |
| Sep 30, 2023 | 6.94% |
| Jun 30, 2023 | 4.46% |
| Mar 31, 2023 | 1.45% |
| Dec 31, 2022 | 2.04% |
| Sep 30, 2022 | 3.53% |
| Jun 30, 2022 | 5.22% |
| Mar 31, 2022 | 8.00% |
| Dec 31, 2021 | 7.02% |
| Sep 30, 2021 | 3.98% |